Effects of Type 1 diabetes mellitus disease on iron metabolism and hepcidin level abstract
Öz
Purpose: The aim of this study was to reveal the relationship between iron metabolism, hepcidin, and hemoglobin A1c (HbA1c) in type 1 diabetes mellitus (T1DM) patients with better and poor metabolic control.
Materials and Methods: The study included 30 T1DM patients with poor metabolic control (HbA1c value >7.5%), 30 T1DM patients with better metabolic control (HbA1c value ≤7.5%), and 30 healthy controls who were of similar age and gender. Routine, hemogram, biochemical tests, iron, transferrin, and ferritin levels were evaluated.
Results: The hepcidin level of the poor metabolic patient group (519.52±114.58) was significantly higher than the control group (431.94±124.05). The ferritin level of the poor metabolic patient group (52.10±36.53) was significantly higher than that of the better metabolic patient group (35.13±36.18) and the control group (28.63±18.08). Positive relationships were found between HbA1c and hepcidin and ferritin. In receiver operating characteristic (ROC) analysis, hepcidin was at the threshold value of 445.20 and had 61.7% sensitivity and 56.0% specificity in diagnosing T1DM.
Conclusion: Hepcidin and ferritin levels have been shown to increase in T1DM patients and both show a positive correlation with HbA1c. Hepcidin may be a promising marker contributing to the follow-up and diagnosis of T1DM.
Anahtar Kelimeler
Type 1 diabetes mellitus, hepcidin, iron metabolism
Destekleyen Kurum
KSU Scientific Research Projects supported this work (2022/3-18 D).
Proje Numarası
KSU Scientific Research Projects supported this work (2022/3-18 D).
Etik Beyan
The KSU Clinical Research Ethics Committee approved this work (2021/17-03).
Teşekkür
KSU Scientific Research Projects supported this work (2022/3-18 D).
Kaynakça
- Quinn LM, Thrower S L, Narendran P. What is type 1 diabetes? Medicine 2022;50:619-24.
- Rusak E, Rotarska-Mizera A, Adamczyk P, Mazur B, Polanska J, Chobot A. Markers of anemia in children with type 1 diabetes. J Diabetes Res. 2018 31;2018:5184354.
- Correnti M, Gammella E, Cairo G, Recalcati S. Iron absorption: molecular and pathophysiological aspects. Metabolites. 2024;14:228.
- Başol G, Barutçuoğlu B, Bozdemir AE. Demir homeostazının yeni düzenleyicisi hepsidin. Türk Klinik Biyokimya Derg. 2007;5:117-25.
- Mojiminiyi OA, Marouf R, Abdella NA. Body iron stores in relation to the metabolic syndrome, glycemic control and complications in female patients with type 2 diabetes. Nutr Metab Cardiovasc Dis. 2008;18:559-66.
- Cooke DW, Plotnick L. Type 1 diabetes mellitus in pediatrics. Pediatr Rev. 2008; 29:374-84.
- AlSaleh A, Ahmed J, Alsenani I, Alhousni W, AalAbdulsalam R, Alshammasi MT. Assessment of quality of life of children and adolescents with type 1 diabetes in bahrain using PedsQL 3.2 diabetes module. J Clin Med. 2025;14:2216.
- Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003; 101:2461-3.
- Sam AH, Busbridge M, Amin A, Webber L, White D, Franks S et al. Hepcidin levels in diabetes mellitus and polycystic ovary syndrome. Diabet Med. 2013;30:1495-9.
- Vreugdenhil M, Akkermans MD, van Swelm RPL, Laarakkers CM, Houdijk ECAM, Bakker B et al. Serum hepcidin concentrations in relation to iron status in children with type 1 diabetes. Pediatr Hematol Oncol. 2021;38:108-23.
